← Back to Clinical Trials
Recruiting NCT06355830

Intermediate Age-related Macular Degeneration - Multimodal Analysis and Longitudinal Study

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Age-Related Macular Degeneration
Sponsor Universidade Nova de Lisboa
Study Type OBSERVATIONAL
Phase N/A
Enrollment 150
Sex ALL
Min Age 55 Years
Max Age 95 Years
Start Date 2019-01-02
Completion 2025-06
Interventions
Orthoptic assessment (Outcome measure)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Study: observational prospective clinical study. Study population: Subjects over 55 years old with drusen secondary to intermediate AMD. Recruitment: at the Medical Retinal Consultation from the Ophthalmology Department of CHULC. Primary outcome: Identifying imaging predictors of iAMD progression.

Eligibility Criteria

Inclusion Criteria: * To verify the existence of drusen secondary to intermediate AMD; Soft, cuticular and reticular pseudo-drusen will be considered. * Accept and sign the consent. Exclusion Criteria: * Patients are excluded if it is not possible to obtain good quality CFP, SD-OCT, OCT-A images, if refractive error is ≥±6D or if there is any evidence of accumulation of extracellular fluid, haemorrhage, exudates or fibrosis. * Additional exclusion criteria included any history of retinal surgery including laser treatment, signs of diabetic retinopathy, history of retinal vascular occlusion, history of anti-VEGF treatment in the study eye or any signs or history of hereditary retinal or macular dystrophy.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}